fbpx
Latest News

Researchers are Planning to Give Nicotine Patches to COVID-19 Patients as Trial Treatment

Scientists are set to give nicotine patches to patients suffering from COVID-19 as a trial treatment to check if they will fight off the novel coronavirus. However, doctors are urging that it is not a reason to smoke, as cigarettes have fatal risks of public health. The World Health Organization also warned that cigarettes increase the risk of contacting novel coronavirus and it can also cause reduce lung capacity and lung disease which would increase the risk of this serious respiratory illness.

French scientists are working on the impact of nicotine patches on the novel coronavirus as the study claimed that infected people who were hospitalized or at their homes were regular smokers as compared to the general population.

The team of researchers suggested that nicotine may prevent the novel coronavirus from infecting cells or nicotine could prevent the immune system from overreacting. The ASH (Action on Smoking and Health) said that the reports suggesting the number of smokers who were hospitalized due to coronavirus is less than the expected ones are uncertain and depend on those who are able to report on their smoking and healthcare workers getting the time for recording it.

Chief executive of ASH, Deborah Arnott said that the UK side effect tracker information is presently demonstrating that smokers are at an elevated risk of contracting symptoms of  COVID-19; persistent cough and fever. There is evidence that smokers who were hospitalized due to coronavirus are at a higher risk as compared to the non-smokers of extreme ailment and demise. Moreover, there are numerous different reasons for smokers to stop smoking for COVID-19, as they are substantially more in danger of the scope of genuine medical issues expecting them to be admitted to the emergency clinic.

Also read- CDC official Warns Second Wave of Coronavirus is Likely to be ‘Even More Difficult’

The reports of the trial conducted in France to check whether nicotine patches can help in preventing or decreasing symptoms of coronavirus must not put smokers off trying to stop, however, urge them to utilize other sources of nicotine to assist them with staying quit. Smokers are considerably more liable to prevail with regards to quit smoking if they utilize other sources of nicotine, for example, e-cigarettes, patches, and gum which are substantially less unsafe than smoking.

To test the hypothesis that nicotine could prevent the novel coronavirus, the researchers will put nicotine patches on infected patients both inside and outside of the ICU, also at forefront workers, to check whether the treatment has any effect on this deadly illness.

For the research which was conducted at Pitié Salpêtrière, the team of researchers examined 480 patients who tested positive for COVID-19.  Out of all participants, 350 patients were in hospitals, and the remaining were treated at their homes.

The outcomes uncovered that of all the patients who were hospitalized, with an average age of 65, just 4.4 percent of them were smokers. In the interim, among patients who were isolated at their homes with an average age of 44, 5.3 percent of them were smokers. Among the general community, 40% of people between 44 years old and 53 years old were smokers, and around 11% of people between 65 years to 75 years also smoke.

The scientists resulted that only some of the smokers have acquired the infection and even after they catch it, their symptoms are mild and not like other standard symptoms. The researchers stated that their cross-sectional examination proposes that the individuals who smoke each day are substantially less prone to build up the asymptomatic or extreme disease with SARS-CoV-2 as compared to the overall population.

The impact is critical. It actually cuts the risk of roaming patients and patients who are admitted to the hospitals. We once in a while observe this in medication. This isn’t the primary article to recommend that nicotine may suppress the symptoms of coronavirus.

Amna Rana

Amna Rana, a writing enthusiast and a microbiologist. Her areas of interest are medical and health care. She writes about diseases, treatments, alternative therapies, lifestyles and the latest news. You can find her on Linkedin Amna Rana.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close

Adblock Detected

Please consider supporting us by disabling your ad blocker